compound · derived
Cabozantinib
0 trials · 1 approval
| Trials | 0 |
|---|---|
| Approvals | 1 |
| Phases | Not stated |
Provenance
- Source: Derived from ClinicalTrials.gov and openFDA
- Fetched at: 2026-10-28T02:31:39.151Z
- Licence class: internal-only
- Verdict: derived
- Entity id: cabozantinib
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.